Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Classification of patients with osteoarthritis through clusters of comorbidities using 633,330 individuals from Spain

Pineda Moncusi M. et al, (2023), Rheumatology

Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK.

Pineda-Moncusí M. et al, (2022), J bone miner res

Osteoarthritis (OA) patients are more likely to have other comorbidities (Swain, Sarmanova et al. 2020). Improving the understanding of comorbidity profiles of OA patients may lead to improvement in their clinical care.

Pineda Moncusi M. et al, (2022)

Unsupervised Learning to Understand Patterns of Comorbidity in 633,330 Patients Diagnosed with Osteoarthritis

Pineda Moncusi M. et al, (2022), Bioinformatics, 3, 121 - 129

Unsupervised Learning to Understand Patterns of Comorbidity in 633,330 Patients Diagnosed with Osteoarthritis

Pineda Moncusi M. et al, (2022), 15th international conference on health informatics

The association between smoking and the development of rheumatoid arthritis: a population-based case-control study.

Sánchez-Campamà J. et al, (2021), Reumatol clin (engl ed), 17, 566 - 569

Costes y beneficios del programa de prevención de fractura FLS en España

PINEDO VILLANUEVA R. et al, (2021)

Effect of vitamin D supplementation on aromatase inhibitor-related musculoskeletal side effects for breast cancer: B-ABLE cohort

Pineda Moncusi M. et al, (2021), Revista de osteoporosis y metabolismo mineral

Calcifediol treatment and COVID-19-related outcomes

Nogues X. et al, (2021), The journal of clinical endocrinology & metabolism

A NEW PREDICTION TOOL BASED ON ELECTRONIC MEDICAL RECORDS DATA TO ASSESS IMMINENT HIP FRACTURE RISK IN SECONDARY FRACTURE PREVENTION: A COHORT ANALYSIS INCLUDING OVER 700,000 PATIENTS FROM DENMARK, SPAIN AND THE UK

Pineda-Moncusi MT. et al, (2020), Osteoporosis international, 31, S52 - S52

DEVELOPMENT AND VALIDATION OF A NEW PREDICTION TOOL TO ASSESS IMMINENT HIP FRACTURE RISK IN PATIENTS STARTING ORAL BISPHOSPHONATES: A REAL WORLD COHORT STUDY INCLUDING 373, 455 PARTICIPANTS FROM DENMARK, SPAIN AND THE UK

Pineda-Moncusi MT. et al, (2020), Osteoporosis international, 31, S401 - S401

The Association Between Smoking and the Development of Rheumatoid Arthritis: A Population-Based Case-Control Study.

Sánchez-Campamà J. et al, (2020), Reumatol clin

Bone tissue quality in patients with monoclonal gammopathy of uncertain significance.

Orduna G. et al, (2020), J bone miner metab, 38, 563 - 569

Persistence to aromatase inhibitors in the SIDIAP cohort: Mortality and influence of bisphosphonates

Pineda-Moncusí M. et al, (2020), Revista de osteoporosis y metabolismo mineral, 12, 87 - 91

Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.

Pineda-Moncusí M. et al, (2020), J bone miner res, 35, 291 - 297

Thromboembolic, cardiovascular and overall mortality risks of aromatase inhibitors, compared with tamoxifen treatment: an outpatient-register-based retrospective cohort study.

Pineda-Moncusí M. et al, (2020), Ther adv med oncol, 12

Long-Term Effect of Aromatase Inhibitors on Fracture Risk Compared to Tamoxifen: a "Real World" Cohort Study of Continued Treatment Up to Ten Years of Follow-Up

Pineda-Moncusi M. et al, (2018), Journal of bone and mineral research, 33, 394 - 394

Include forthcoming?